Alexandria Real Estate Equities-backed exosome therapeutics developer Codiak BioSciences is eyeing up to $86.3m in a forthcoming IPO.

The immuno-oncology therapy developer received funding from investors including Alexandria Real Estate Equities and strategic collaborator Celgene.

Scottish Investment Bank and Innovate UK were among those backing University of Strathclyde brain cancer diagnosis spinout ClinSpec Diagnostics.

The Eli Lilly and Mitsui-backed drug developer has received $11m in a round led by Cell Innovation Partners, taking its overall funding to more than $83m.

Taikang Life Insurance backed a $14.8m round for the online medical data platform, which already counts Fosun, DXY and Meituan Dianping as shareholders.

908 Devices plans to add a life science device to its chemical detection product range, having landed $17.5m in a Schlumberger and Saudi Aramco-backed round.

Telus Ventures is set to exit healthcare data management software producer Get Real Health in an $11m purchase by CPSI, six years after it invested.

The 12-week medtech and digital health accelerator is also being supported by medical care provider Hartford HealthCare and will onboard its first ten startups in June 2019.

Sohaib Mir has earned a promotion to principal having joined Cambridge Innovation Capital to provide business expertise in the life science space in 2014.

MRCF has reached the first close of a CSL-backed fifth fund to make early-stage investments in medical technologies in Australia and New Zealand.